The role of vitamin D in reproductive health—a trojan horse or the golden fleece?

Nutrients

Volumn 7, Issue 6, 2015, Pages 4139-4153

  Dabrowski, Filip A ^a   Grzechocinska, Barbara ^a   Wielgos, Miroslaw ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

ART; Endometriosis infertility; In vitro fertilization; Infertility; Male infertility; Myoma infertility; Polycystic ovary syndrome; Premature ovary failure; Vitamin D

Indexed keywords

COLECALCIFEROL; VITAMIN D;

ASTHENOSPERMIA; ENDOMETRIOSIS; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; INSULIN RESISTANCE; MALE INFERTILITY; OBESITY; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; REPRODUCTIVE HEALTH; REVIEW; SPERMATOZOON; UTERUS MYOMA; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; BLOOD; DIETARY SUPPLEMENT; FEMALE; MALE; PREMATURE OVARIAN FAILURE; REPRODUCTION;

EQUIDAE;

DIETARY SUPPLEMENTS; ENDOMETRIOSIS; FEMALE; HUMANS; INFERTILITY; INSULIN RESISTANCE; MALE; OBESITY; POLYCYSTIC OVARY SYNDROME; PRIMARY OVARIAN INSUFFICIENCY; REPRODUCTION; REPRODUCTIVE HEALTH; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84930959746     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7064139     Document Type: Review

References (70)

1. Lerchbaum, E.; Rabe, T. Vitamin D and female fertility. Curr. Opin. Obstet. Gynecol.2014, 26, 145–150
2. Grzechocinska, B.; Dabrowski, F.A.; Cyganek, A.; Wielgos, M. The role of vitamin D in impaired fertility treatment. Neuro Endocrinol. Lett.2013, 34, 756–762
3. Mellanby, E. An experimental investigation of rickets. Lancet1919, 1, 407–412
4. Pettifor, J.M. Calcium and vitamin D metabolism in children in developing countries. Ann. Nutr. Metab.2014, 64, 15–22
5. Pettifor, J.M. How should we manage vitamin D deficiency rickets? Indian Pediatr. 2014, 51, 259–260
6. D’Aurizio, F.; Villalta, D.; Metus, P.; Doretto, P.; Tozzoli, R. Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases? Autoimmun. Rev.2015, 14, 363–369
7. Delvin, E.; Souberbielle, J.C.; Viard, J.P.; Salle, B. Role of vitamin D in acquired immune and autoimmune diseases. Crit. Rev. Clin. Lab. Sci.2014, 51, 232–247
8. Mascarenhas, M.N.; Flaxman, S.R.; Boerma, T.; Vanderpoel, S.; Stevens, G.A. National, regional, and global trends in infertility prevalence since 1990: A systematic analysis of 277 health surveys. PLoS Med. 2012, 9, e1001356
9. Prosser, D.E.; Jones, G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem. Sci.2004, 29, 664–673
10. Rosen, C.J.; Abrams, S.A.; Aloia, J.F.; Brannon, P.M.; Clinton, S.K.; Durazo-Arvizu, R.A.; Gallagher, J.C.; Gallo, R.L.; Jones, G.; Kovacs, C.S.; et al. IOM committee members respond to Endocrine Society vitamin D guideline. Clin. Endocrinol. Metab. 2012, 97, 1146–1152
11. Pludowski, P.; Holick, M.F.; Pilz, S.; Wagner, C.L.; Hollis, B.W.; Grant, W.B.; Shoenfeld, Y.; Lerchbaum, E.; Llewellyn, D.J.; Kienreich, K.; Soni, M. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun. Rev.2013, 12, 976–989
12. Grant, W.B.; Wimalawansa, S.J.; Holick, M.F.; Cannell, J.J.; Pludowski, P.; Lappe, J.M.; Pittaway, M.; May, P. Emphasizing the Health Benefits of Vitamin D for Those with Neurodevelopmental Disorders and Intellectual Disabilities. Nutrients2015, 7, 1538–1564
13. Christakos, S.; Dhawan, P.; Benn, B.; Porta, A.; Hediger, M.; Oh, G.T.; Jeung, E.B.; Zhong, Y.; Ajibade, D.; Dhawan, K.; Joshi, S. Vitamin D: Molecular mechanism of action. Ann. N. Y. Acad. Sci.2007, 1116, 340–348
14. Luk, J.; Weisman, Y.; Harell, A.; Edelstein, S.; David, M.; Spirer, Z.; Golander, A. 1 alpha, 25-Dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta. Nature 1979, 281, 317–319
15. Evans, K.; Nguyen, L.; Chan, J.; Innes, B.A.; Bulmer, J.N.; Kilby, M.; Hewison, M. Effects of 25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 on Cytokine Production by Human Decidual Cells. Biol. Reprod.2006, 75, 816–822
16. Pérez-Fernandez, R.; Alonso, M.; Segura, C.; Muñoz, I.; García-Caballero, T.; Diguez, C. Vitamin D receptor gene expression in human pituitary gland. Life Sci. 1997, 60, 35–42
17. Parikh, G.; Varadinova, M.; Suwandhi, P.; Araki, T.; Rosenwaks, Z.; Poretsky, L.; Seto-Young, D. Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells. Horm. Metab. Res.2010, 42, 754–757
18. Torrealday, S.; Neal Perry, G.; Pal, L. Relevance of vitamin D in reproduction. Hum. Reprod.2012, 27, 3015–3027
19. Aquila, S.; Guido, C.; Middea, E.; Perrotta, I.; Bruno, R.; Pellegrino, M.; Andò, S. Human male gamete endocrinology: 1alpha, 25-dihydroxyvitamin D3 (1,25(OH)2D3)regulates different aspects of human sperm biology and metabolism. Reprod. Biol. Endocrinol.2009, 7, 140
20. Habib, F.K.; Maddy, S.Q.; Gelly, K.J. Characterisation of receptors for 1,25-dihydroxyvitamin D3 in the human testis. J. Steroid Biochem.1990, 35, 195–199
21. Sirmans, S.M.; Pate, K.A. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin. Epidemiol.2013, 6, 1–13
22. Azziz, R.; Carmina, E.; Dewailly, D.; Diamanti-Kandarakis, E.; Escobar-Morreale, H.F.; Futterweit, W.; Janssen, O.E.; Legro, R.S.; Norman, R.J.; Taylor, A.E.; et al. Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline. J. Clin. Endocrinol. Metab. 2006, 91, 4237–4245
23. Ricardo, A. Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature. J. Clin. Endocrinol. Metab.2006, 91, 781–785
24. Thomson, R.L.; Spedding, S.; Buckley, J.D. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin. Endocrinol. (Oxf.)2012, 77, 343–350
25. Irani, M.; Minkoff, H.; Seifer, D.B.; Merhi, Z. Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS. J. Clin. Endocrinol. Metab.2014, 99, E886–E890
26. Irani, M.; Merhi, Z. Role of vitamin D in ovarian physiology and its implication in reproduction: A systematic review. Fertil. Steril. 2014, 102, 460–468
27. Patra, S.K.; Nasrat, H.; Goswami, B.; Jain, A. Vitamin D as a predictor of insulin resistance in polycystic ovarian syndrome. Diabetes Metab. Syndr.2012, 6, 146–149
28. Ott, J.; Wattar, L.; Kurz, C.; Seemann, R.; Huber, J.C.; Mayerhofer, K.; Vytiska-Binstorfer, E. Parameters for calcium metabolism in women with polycystic ovary syndrome who undergo clomiphene citrate stimulation: A prospective cohort study. Eur. J. Endocrinol.2012, 166, 897–902
29. Wehr, E.; Pilz, S.; Schweighofer, N.; Giuliani, A.; Kopera, D.; Pieber, T.R.; Obermayer-Pietsch, B. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur. J. Endocrinol.2009, 161, 575–582
30. Yildizhan, R.; Kurdoglu, M.; Adali, E.; Kolusari, A.; Yildizhan, B.; Sahin, H.G.; Kamaci, M. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch. Gynecol. Obstet.2009, 280, 559–563
31. Christakos, S.; Hewison, M.; Gardner, D.G.; Wagner, C.L.; Sergeev, I.N.; Rutten, E.; Pittas, A.G.; Boland, R.; Ferrucci, L.; Bikle, D.D. Vitamin D: Beyond bone. Ann. N. Y. Acad. Sci.2013, 1287, 45–58
32. Nestler, J.E.; Reilly, E.R.; Cheang, K.I.; Bachmann, L.M.; Downs, R.W., Jr. A pilot study: Effects of decreasing serum insulin with diazoxide on vitamin D levels in obese women with polycystic ovary syndrome. Trans. Am. Clin. Climatol. Assoc.2012, 123, 209–220
33. Paffoni, A.; Somigliana, E.; Vigano, P.; Benaglia, L.; Cardellicchio, L.; Pagliardini, L.; Papaleo, E.; Candiani, M.; Fedele, L. Vitamin D status in women with uterine leiomyomas. J. Clin. Endocrinol. Metab.2013, 98, E1374–E1378
34. Ginde, A.A.; Liu, M.C.; Camargo, C.A., Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch. Intern. Med.2009, 169, 626–632
35. Wise, L.A.; Ruiz-Narváez, E.A.; Haddad, S.A.; Rosenberg, L.; Palmer, J.R. Polymorphisms in vitamin D-related genes and risk of uterine leiomyomata. Fertil. Steril.2014, 102, 503–510
36. Halder, S.K.; Sharan, C.; Al-Hendy, O.; Al-Hendy, A. Paricalcitol, a vitamin d receptor activator, inhibits tumor formation in a murine model of uterine fibroids. Reprod. Sci.2014, 21, 1108–1119
37. Yildirim, B.; Guler, T.; Akbulut, M.; Oztekin, O.; Sariiz, G. 1-alpha,25-dihydroxyvitamin D3 regresses endometriotic implants in rats by inhibiting neovascularization and altering regulation of matrix metalloproteinase. Postgrad Med. 2014, 126, 104–110
38. Di Rosa, M.; Malaguarnera, G.; De Gregorio, C.; Palumbo, M.; Nunnari, G.; Malaguarnera, L. Immuno-modulatory effects of vitamin D3 in human monocyte and macrophages. Cell Immunol. 2012, 280, 36–43
39. Somigliana, E.; Panina-Bordignon, P.; Murone, S.; Di Lucia, P.; Vercellini, P.; Vigano, P. Vitamin D reserve is higher in women with endometriosis. Hum. Reprod.2007, 22, 2273–2278
40. Mormile, R.; Vittori, G. Vitamin D intake and endometriosis: The good and the bad. Eur. J. Obstet. Gynecol. Reprod. Biol. 2014, 177, 152–153
41. Visser, J.A.; Frank, H.J.; Joop, S.; Laven, E.; Axel, P.N. Themmen Anti-Müllerian hormone: A new marker for ovarian function. Reproduction2006, 131, 1–9
42. Kelsey, T.W.; Wright, P.; Nelson, S.M.; Anderson, R.A.; Wallace, W.H.B. A validated model of serum anti-Müllerian hormone from conception to menopause. PLoS ONE 2011, 6, doi:10.1371/journal.pone.0022024
43. Seifer, D.B.; Maclaughlin, D.T. Review Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance. Fertil. Steril.2007, 88, 539–546
44. Chang, E.M.; Kim, Y.S.; Won, H.J.; Yoon, T.K.; Lee, W.S. Association between sex steroids, ovarian reserve, and vitamin D levels in healthy nonobese women. J. Clin. Endocrinol. Metab.2014, 99, 2526–2532
45. Malloy, P.J.; Peng, L.; Wang, J.; Feldman, D. Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: Regulation of MIS expression by calcitriol in prostate cancer cells. Endocrinology2009, 150, 1580–1587
46. Merhi, Z.O.; Seifer, D.B.; Weedon, J.; Adeyemi, O.; Holman, S.; Anastos, K.; Golub, E.T.; Young, M.; Karim, R.; Greenblatt, R.; Minkoff, H. Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women’s InteragencyHIV Study. Fertil. Steril.2012, 98, 228–234
47. Sun, W.; Chen, L.; Zhang, W.; Wang, R.; Goltzman, D.; Miao, D. Active vitamin D deficiency mediated by extracellular calcium and phosphorus results in male infertility in young mice. Am. J. Physiol. Endocrinol. Metab.2015, 308, E51–E62
48. Blomberg Jensen, M.; Bjerrum, P.J.; Jessen, T.E.; Nielsen, J.E.; Joensen, U.N.; Olesen, I.A.; Petersen, J.H.; Juul, A.; Dissing, S.; Jørgensen, N. Vitamin D is positively associated with sperm motility and increases intracellular calcium in human spermatozoa. Hum. Reprod.2011, 26, 1307–1317
49. Blomberg Jensen, M. Vitamin D and male reproduction. Nat. Rev. Endocrinol.2014, 10, 175–186
50. Yu, H.M.; Li, X.J.; Kadam, A.L.; Cheng, C.Y.; Koide, S.S. Human testis vitamin D Winding protein involved in infertility. Arch. Androl.1994, 33, 119–128
51. Yang, B.; Sun, H.; Wan, Y.; Wang, H.; Qin, W.; Yang, L.; Zhao, H.; Yuan, J.; Yao, B. Associations between testosterone, bone mineral density, vitamin D and semen quality in fertile and infertile Chinese men. Int. J. Androl.2012, 35, 783–792
52. Ramlau-Hansen, C.H.; Moeller, U.K.; Bonde, J.P.; Olsen, J.; Thulstrup, A.M. Are serum levels of vitamin D associated with semen quality? Results from a cross-sectional study in young healthy men. Fertil. Steril.2011, 95, 1000–1004
53. Hammoud, A.O.; Meikle, A.W.; Peterson, C.M.; Stanford, J.; Gibson, M.; Carrell, D.T. Association of 25-hydroxy-vitamin D levels with semen and hormonal parameters. Asian J. Androl.2012, 14, 855–859
54. Ozkan, S.; Jindal, S.; Greenseid, K.; Shu, J.; Zeitlian, G.; Hickmon, C.; Pal, L. Replete vitamin D stores predict reproductive success following in vitro fertilization. Fertil. Steril.2010, 94, 1314–1349
55. Rudick, B.; Ingles, S.; Chung, K.; Stanczyk, F.; Paulson, R.; Bendikson, K. Characterizing the influence of vitamin D levels on IVF outcomes. Hum. Reprod.2012, 27, 3321–3327
56. Rudick, B.J.; Ingles, S.A.; Chung, K.; Stanczyk, F.Z.; Paulson, R.J.; Bendikson, K.A. Influence of vitamin D levels on in vitro fertilization outcomes in donor-recipient cycles. Fertil. Steril.2014, 101, 447–452
57. Fabris, A.; Pacheco, A.; Cruz, M.; Puente, J.M.; Fatemi, H.; Garcia-Velasco, J.A. Impact of circulating levels of total and bioavailable serum vitamin D on pregnancy rate in egg donation recipients. Fertil. Steril.2014, 102, 1608–1612
58. Van Etten, E.; Decallonne, B.; Verlinden, L.; Verstuyf, A.; Bouillon, R.; Mathieu, C. Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulators. J. Cell Biochem.2003, 88, 223–226
59. Bomba-Opon, D.; Brawura-Biskupski-Samaha, R.; Kozlowski, S.; Kosinski, P.; Bartoszewicz, Z.; Bednarczuk, T.; Wielgos, M. First trimester maternal serum vitamin D and markers of preeclampsia. J. Matern. Fetal Neonatal. Med. 2013. [Epub ahead of print] PubMed PMID: 24050181
60. Firouzabadi, R.D.; Rahmani, E.; Rahsepar, M.; Firouzabadi, M.M. Value of follicular fluid vitamin D in predicting the pregnancy rate in an IVF program. Arch. Gynecol. Obstet.2014, 289, 201–206
61. Anifandis, G.M.; Dafopoulos, K.; Messini, C.I.; Chalvatzas, N.; Liakos, N.; Pournaras, S.; Messinis, I.E. Prognostic value of follicular fluid 25-OH vitamin D and glucose levels in the IVF outcome. Reprod. Biol. Endocrinol.2010, 8, 91
62. Zerah, S.; de Mouzon, J.; Pfeffer, J.; Taar, J.P. Seasonal variation in sperm characteristics. Contracept Fertil Sex. 1997, 25, 519–523. (in French)
63. Pal, L.; Kidwai, N.; Kayani, J.; Grant, W.B. Donor egg IVF model to assess ecological implications for ART success. J. Assist. Reprod. Genet.2014, 31, 1453–1460
64. Bodnar, L.M.; Catov, J.M.; Simhan, H.N.; Holick, M.F.; Powers, R.W.; Roberts, J.M. Maternal vitamin D deficiency increases the risk of preeclampsia. J. Clin. Endocrinol. Metab.2007, 92, 3517–3522
65. Poreba, R.; Drews, K.; Karowicz-Bilińska, A.; Oszukowski, P.; Pawelczyk, L.; Radowicki, S.; Spaczyński, M.; Szczapa, J.; Zespołu Ekspertów Polskiego Towarzystwa Ginekologicznego. Expert review of Polish Gynecological Society regarding micronutrient supplementation in pregnancy. Ginekol. Pol.2011, 82, 550–553
66. Ross, A.C.; Manson, J.E.; Abrams, S.A.; Aloia, J.F.; Brannon, P.M.; Clinton, S.K.; Durazo-Arvizu, R.A.; Gallagher, J.C.; Gallo, R.L.; Jones, G.; et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J. Clin. Endocrinol. Metab. 2011, 96, 53–58
67. Garland, C.F.; Kim, J.J.; Mohr, S.B.; Gorham, E.D.; Grant, W.B.; Giovannucci, E.L.; Baggerly, L.; Hofflich, H.; Ramsdell, J.W.; Zeng, K.; Heaney, R.P. Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D. Am. J. Public Health.2014, 104, e43–e50
68. Wagner, C.L.; Hulsey, T.C.; Fanning, D.; Ebeling, M.; Hollis, B.W. High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: A 6-month follow-up pilot study. Breastfeed. Med. 2006, 1, 59–70
69. Holick, M.F.; Binkley, N.C.; Bischoff-Ferrari, H.A.; Gordon, C.M.; Hanley, D.A.; Heaney, R.P.; Murad, M.H.; Weaver, C.M. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96, 1911–1130. doi: 10.1210/jc.2011-0385
70. Płudowski, P.; Karczmarkiewicz, E.; Bayer, M.; Carter, G.; Chlebna-Sokół, D.; Czech-Kowalska, J.; Dębski, R.; Decsi, T.; Dobrzańska, A.; Franek, E.; et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe – recommended vitamin D intakes in general population and group at risk of vitamin D deficiency. Endokrynol. Pol. 2013, 64, 319–327.